Skip to main navigation Skip to main content Skip to footer For Medicare For Providers For Brokers For Employers Español For Individuals & Families: For Individuals & Families Medical Dental Other Supplemental Explore coverage through work How to Buy Health Insurance Types of Dental Insurance Open Enrollment vs. Special Enrollment See all topics Shop for Medicare plans Member Guide Find a Doctor Log in to myCigna
Home Knowledge Center Wellness Library Pregnancy and Epilepsy

Pregnancy and Epilepsy

Overview

Most of the time, people with epilepsy who become pregnant deliver healthy babies. But the risk of birth defects, stillbirth, and seizure-related problems is higher for babies born to someone with epilepsy. Most antiepileptic medicines increase the risk even more.

If you have epilepsy and become pregnant, stopping medicine treatment is not always the best solution. Having seizures during pregnancy can also harm the baby. And pregnancy causes changes in your body that may increase the frequency of seizures.

The following information is based on guidelines from the American Academy of Neurology.footnote 1,footnote 2

Before you become pregnant

Before you become pregnant, talk with your doctor about your epilepsy treatment. Seizures or seizure medicine may cause damage to the baby very early in your pregnancy, before you even know that you are pregnant. Your doctor will help you consider whether potential seizures or continued use of antiepileptic medicine poses the greater risk to your baby.

In general, the recommendation is to only use one medicine for epilepsy and to use it at the lowest possible dose to avoid potential problems from the medicine. Medicines may not harm a baby as much as seizures during pregnancy may.

If you are not yet pregnant but are planning to become pregnant, stopping medicine might be an option if you have been seizure-free for several years. Your doctor may suggest a trial run without the medicine before you become pregnant. Experts recommend that this trial run take place at least 6 months before the pregnancy so that you and your doctor can see the results of stopping your treatment. If you begin having seizures, you may need to go back on medicine.

While you are pregnant

If you need to stay on medicine during your pregnancy, your doctor may suggest some changes in your treatment that reduce the risk of birth defects. These changes may include:

  • Switching to a medicine that is safer for the baby.
  • Taking a single medicine.
  • Changing the medicine dosage.
  • Having blood tests to make sure you have the right levels of seizure medicine in your body.
  • Taking folic acid or other supplements before you get pregnant and during your pregnancy. (Folic acid reduces the risk of some birth defects.)

You may put yourself and your baby at greater risk if you change, reduce, or stop taking your medicine while you are pregnant. Talk with your doctor first.

Other concerns

  • During your pregnancy, you may need more frequent checkups to monitor the baby's condition and blood tests to monitor your drug levels.
  • After birth, it's very important for your baby to get the routine vitamin K shot. (Some antiepileptic medicines can cause a temporary blood disorder in newborns that makes it hard for their blood to clot normally. Vitamin K can help reverse this problem.) Your doctor may recommend that you take vitamin K during your pregnancy.
  • Breastfeeding while you are taking antiepileptic medicine is usually safe. But talk to your doctor about any concerns you have. If you are taking a barbiturate (such as phenobarbital) to control your seizures, breastfeeding may make the baby drowsy or irritable, because the drug may get into your breast milk.

If you have epilepsy and find out that you are pregnant, talk with your doctor right away. Do not stop taking your medicine without first talking to your doctor.

References

References

Citations

  1. Harden CL, et al. (2009). Practice parameter update: Management issues for women with epilepsy—Focus on pregnancy (an evidence-based review): Teratogenesis and perinatal outcomes: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology, 73(2): 133–141.
  2. Harden CL, et al. (2009). Practice parameter update: Management issues for women with epilepsy—Focus on pregnancy (an evidence-based review): Vitamin K, folic acid, blood levels, and breastfeeding: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology, 73(2): 142–149.

Current as of: December 20, 2023

Author: Ignite Healthwise, LLC Staff

Clinical Review Board
All Healthwise education is reviewed by a team that includes physicians, nurses, advanced practitioners, registered dieticians, and other healthcare professionals.

This information does not replace the advice of a doctor. Ignite Healthwise, LLC, disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Learn how we develop our content.

© 2024 Ignite Healthwise, LLC. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Ignite Healthwise, LLC.

Related Links

Pregnancy Epilepsy

<cipublic-spinner variant="large"><span>Loading…</span></cipublic-spinner>

Page Footer

I want to...

Get an ID card File a claim View my claims and EOBs Check coverage under my plan See prescription drug list Find an in-network doctor, dentist, or facility Find a form Find 1095-B tax form information View the Cigna Glossary Contact Cigna

Audiences

Individuals and Families Medicare Employers Brokers Providers

Secure Member Sites

myCigna member portal Health Care Provider portal Cigna for Employers Client Resource Portal Cigna for Brokers

The Cigna Group Information

About Cigna Healthcare Company Profile Careers Newsroom Investors Suppliers The Cigna Group Third Party Administrators International Evernorth

 Cigna. All rights reserved.

Privacy Legal Product Disclosures Cigna Company Names Customer Rights Accessibility Non-Discrimination Notice Language Assistance [PDF] Report Fraud Sitemap Cookie Settings

Disclaimer

Individual and family medical and dental insurance plans are insured by Cigna Health and Life Insurance Company (CHLIC), Cigna HealthCare of Arizona, Inc., Cigna HealthCare of Illinois, Inc., Cigna HealthCare of Georgia, Inc., Cigna HealthCare of North Carolina, Inc., Cigna HealthCare of South Carolina, Inc., and Cigna HealthCare of Texas, Inc. Group health insurance and health benefit plans are insured or administered by CHLIC, Connecticut General Life Insurance Company (CGLIC), or their affiliates (see a listing of the legal entities that insure or administer group HMO, dental HMO, and other products or services in your state). Accidental Injury, Critical Illness, and Hospital Care plans or insurance policies are distributed exclusively by or through operating subsidiaries of Cigna Corporation, are administered by Cigna Health and Life Insurance Company, and are insured by either (i) Cigna Health and Life Insurance Company (Bloomfield, CT); (ii) Life Insurance Company of North America (“LINA”) (Philadelphia, PA); or (iii) New York Life Group Insurance Company of NY (“NYLGICNY”) (New York, NY), formerly known as Cigna Life Insurance Company of New York. The Cigna name, logo, and other Cigna marks are owned by Cigna Intellectual Property, Inc. LINA and NYLGICNY are not affiliates of Cigna.

All insurance policies and group benefit plans contain exclusions and limitations. For availability, costs and complete details of coverage, contact a licensed agent or Cigna sales representative. This website is not intended for residents of New Mexico.

Selecting these links will take you away from Cigna.com to another website, which may be a non-Cigna website. Cigna may not control the content or links of non-Cigna websites. Details